Last $0.48 USD
Change Today 0.00 / 0.00%
Volume 0.0
RAFA On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/11/14 All times are local (Market data is delayed by at least 15 minutes).

rafarma pharmaceuticals inc (RAFA) Snapshot

Open
$0.48
Previous Close
$0.48
Day High
$0.48
Day Low
$0.48
52 Week High
07/17/13 - $0.80
52 Week Low
05/31/13 - $0.04
Market Cap
1.7M
Average Volume 10 Days
8.6K
EPS TTM
--
Shares Outstanding
3.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RAFARMA PHARMACEUTICALS INC (RAFA)

Related News

No related news articles were found.

rafarma pharmaceuticals inc (RAFA) Related Businessweek News

No Related Businessweek News Found

rafarma pharmaceuticals inc (RAFA) Details

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in the Russian Federation. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in the Russian Federation.

rafarma pharmaceuticals inc (RAFA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rafarma pharmaceuticals inc (RAFA) Key Developments

Rafarma Pharmaceuticals Announces the Complete Restructuring of Existing EUR 90,000,000 Loan with VNeshconombank

Rafarma Pharmaceuticals Inc. announced the complete restructuring of its existing EUR 90,000,000.00 loan with VNeshconombank (VEBank). Terms and conditions of the restructured loan include a 3-year deferment, or holiday, on all principal and interest payments thus greatly enhancing the financial stability of the company.

Rafarma Pharmaceuticals, Inc. Enters New Distribution Agreement with Amber Pharma Distribution Group

Rafarma Pharmaceuticals, Inc. announced it has entered into a new multi-year distribution contract with Amber Pharma Distribution Group.

New Dialysis Research and Development Center of Rafarma Pharmaceuticals, Inc. Devotes to Dialysis Research and Product Development

The success of Rafarma Pharmaceuticals, Inc. in choosing Terbuny for its facility has attracted more biotech companies to the area. A new facility specifically devoted to dialysis research and product development has been announced. The new facility will be located near Rafarma's already-operating pharmaceutical plant in Terbuny in the Lipetsk region of Russia, a few hours south from Moscow. Rafarma and the dialysis facility plan to work in close cooperation in the development of dialysis-specific products. Terbuny is part of a special economic development region to promote economic growth and jobs in the area. For building and maintaining its facilities in Terbuny, as well as hiring local residents, Rafarma enjoys specific government incentives which enhance its bottom line.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RAFA:US $0.48 USD 0.00

RAFA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RAFA.
View Industry Companies
 

Industry Analysis

RAFA

Industry Average

Valuation RAFA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RAFARMA PHARMACEUTICALS INC, please visit www.rafarma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.